Peculiaridades da farmacoterapêutica cardiovascular no idoso

Batlouni, Michel; Gravina, Cláudia F.
Rev. Soc. Cardiol. Estado de Säo Paulo ; 17(1): 20-33, jan.-mar. 2007.
Artículo en Portugués | LILACS, SES-SP | ID: lil-458213

Documentos relacionados

  1. An Industry Survey With Focus on Cardiovascular Safety Pharmacology Study Design and Data Interpretation.
  2. High-dimensionality Data Analysis of Pharmacological Systems Associated with Complex Diseases.
  3. Systems Pharmacology Dissection of Mechanisms of Dengzhan Xixin Injection against Cardiovascular Diseases.
  4. Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases.
  5. Machine learning for synergistic network pharmacology: a comprehensive overview.
  6. Digital medicine: the next big leap advancing cardiovascular science.
  7. The Emerging Role of B Lymphocytes in Cardiovascular Disease.
  8. Multiomics Network Medicine Approaches to Precision Medicine and Therapeutics in Cardiovascular Diseases.
  9. Recent applications of quantitative systems pharmacology and machine learning models across diseases.
  10. Some personal thoughts on the Australasian Society of Clinical and Experimental Pharmacologists in the 1980s.